Letter to the EditorFirst report of metronidazole-induced QT interval prolongation
References (7)
- et al.
Long QT syndrome caused by non-cardiac drugs
Prog Cardiovasc Dis
(2003) - et al.
Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports
Mycoses
(2006) - et al.
Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole?
Ann Pharmacother
(1996)
There are more references available in the full text version of this article.
Cited by (10)
Antimicrobial agents and torsades de pointes
2022, Torsades de PointesMetronidazole
2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious DiseasesAntiprotozoal drugs
2010, Side Effects of Drugs AnnualCitation Excerpt :For sulfonamides and co-trimoxazole (trimethoprim + sulfamethoxazole), seeChapter 26. QT interval prolongation after metronidazole has been described (20A). A 90-year-old woman with Parkinson’s disease and osteoporosis was given intravenous ceftriaxone 1 g/day and metronidazole 500 mg tds for an aspiration pneumonia; her other medications included levodopa and calcium.
Perioperative acquired long QT syndrome: a case report
2010, Revista Espanola de Anestesiologia y ReanimacionMetronidazole
2017, Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh EditionAn unusual presentation of QT prolongation
2016, Texas Heart Institute Journal
Copyright © 2007 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.